RMED - Ra Medical Systems, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue6,2575,8705,976
Cost of Revenue4,2064,1653,138
Gross Profit2,0511,7052,838
Operating Expenses
Research Development2,7764,5181,715
Selling General and Administrative30,43514,7475,321
Non Recurring---
Total Operating Expenses37,41723,43010,174
Operating Income or Loss-31,160-17,560-4,198
Income from Continuing Operations
Total Other Income/Expenses Net338-204-3
Earnings Before Interest and Taxes-31,160-17,560-4,198
Interest Expense-14-4-3
Income Before Tax-30,822-17,764-4,201
Income Tax Expense1011
Minority Interest---
Net Income From Continuing Ops-30,832-17,765-4,202
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-30,832-17,765-4,202
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-30,832-17,765-4,202